A population-based assessment of mortality and morbidity patterns among patients with thymoma

International Journal of Cancer

Volumn 128, Issue 11, 2011, Pages 2688-2694

  Gadalla, Shahinaz M ^a   Rajan, Arun ^a   Pfeiffer, Ruth ^a   Kristinsson, Sigurdur Y ^b   Björkholm, Magnus ^b   Landgren, Ola ^a   Giaccone, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

autoimmunity; second cancer; thymoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE TUMOR; ERYTHROCYTE APLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYASTHENIA GRAVIS; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTATE CANCER; SCHOOL CHILD; SECOND CANCER; SKIN CANCER; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOMA; UTERINE CERVIX CANCER;

ADULT; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; SURVIVAL RATE; SWEDEN; THYMOMA; THYMUS NEOPLASMS;

EID: 79953324183     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25583     Document Type: Article

References (25)

1. Schmidt-Wolf IG, Rockstroh JK, Schuller H, Hirner A, Grohe C, Muller-Hermelink HK, Huhn D,. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol 2003; 82: 69-76. (Pubitemid 36700977)
2. Detterbeck FC, Parsons AM,. Thymic tumors. Ann Thorac Surg 2004; 77: 1860-9. (Pubitemid 38530055)
3. Shields TW,. Primary lesions of the mediastinum and their investigation and treatment, 4th edn. Baltimore: Williams and Wilkins Publishers, 1994. 1724-96.
4. Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della MG, Lauriola L, Fattorossi A,. Paraneoplastic diseases associated with thymoma. J Neurol 2007; 254: 756-62. (Pubitemid 47012452)
5. Kondo K, Monden Y,. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg 2005; 79: 219-24. (Pubitemid 40037475)
6. Monden Y, Uyama T, Taniki T, Hashimoto J, Fujii Y, Nakahara K, Kawashima Y, Masaoka A,. The characteristics of thymoma with myasthenia gravis: a 28-year experience. J Surg Oncol 1988; 38: 151-4.
7. Engels EA, Pfeiffer RM,. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003; 105: 546-51. (Pubitemid 36578561)
8. Pan CC, Chen PC, Wang LS, Chi KH, Chiang H,. Thymoma is associated with an increased risk of second malignancy. Cancer 2001; 92: 2406-11. (Pubitemid 33029086)
9. Travis LB, Boice JD, Jr, Travis WD,. Second primary cancers after thymoma. Int J Cancer 2003; 107: 868-70.
10. Welsh JS, Wilkins KB, Green R, Bulkley G, Askin F, ener-West M, Howard SP,. Association between thymoma and second neoplasms. JAMA 2000; 283: 1142-3.
11. de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ,. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 2008; 44: 123-30. (Pubitemid 50009874)
12. Rosai J, Sobin LH,; World Health Organization. Histological typing of tumors of the thymus, 2nd ed. Berlin: Springer Verlag, 1999.
13. Tomaszek S, Wigle DA, Keshavjee S, Fischer S,. Thymomas: review of current clinical practice. Ann Thorac Surg 2009; 87: 1973-80.
14. Nishioka R, Nakajima S, Morimoto Y, Suzuki H, Nakamura H, Suzuki M,. T-cell acute lymphoblastic leukemia with transient pure red cell aplasia associated with myasthenia gravis and invasive thymoma. Intern Med 1995; 34: 127-30.
15. Barritt AW, Bacsi AM, Tschuchnigg M, Sharpe D, Kiernan MC,. Myasthenia gravis seven years after removal of an invasive thymoma. J Clin Neurosci 2009; 16: 966-8.
16. Thomas CR, Wright CD, Loehrer PJ,. Thymoma: state of the art. J Clin Oncol 1999; 17: 2280-9. (Pubitemid 29318862)
17. Bjorkholm M, Holm G, Mellstedt H, Carlberger G, Nisell J,. Membrane bound IgG on erythroblasts in pure red cell aplasia following thymectomy. A case report. Scand J Haematol 1976; 17: 341-6.
18. Ströbel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumägi A, Sillanpää N, Peterson P, Hummel V, Rieckmann P, Burek C, Schalke B, et al. Selective loss of regulatory T cells in thymomas. Ann Neurol 2004; 56: 901-4. (Pubitemid 39578459)
19. Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, Kadota Y, Sawa Y,. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008; 56: 143-50. (Pubitemid 351514680)
20. Bjorkholm M, Holm G, Johansson B, Mellstedt H,. T-Lymphocyte deficiency following adult thymectomin man. Scand J Haematol 1975; 14: 210-5.
21. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ,. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-94. (Pubitemid 351705208)
22. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK,. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002; 95: 420-9. (Pubitemid 34787609)
23. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y,. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 2004; 77: 1183-8. (Pubitemid 38452343)
24. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A,. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002; 94: 624-32. (Pubitemid 34132289)
25. Rena O, Papalia E, Maggi G, Oliaro A, Ruffini E, Filosso P, Mancuso M, Novero D, Casadio C,. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005; 50: 59-66. (Pubitemid 41297470)